Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Shares Outstanding (2016 - 2025)

Neuroone Medical Technologies' Shares Outstanding history spans 14 years, with the latest figure at $50.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 63.46% year-over-year to $50.4 million; the TTM value through Dec 2025 reached $50.4 million, up 63.46%, while the annual FY2025 figure was $50.0 million, 62.27% up from the prior year.
  • Shares Outstanding reached $50.4 million in Q4 2025 per NMTC's latest filing, up from $50.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $50.4 million in Q4 2025 to a low of $11.9 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $24.9 million, with a median of $20.9 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: surged 110.32% in 2021, then grew 0.31% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $16.2 million in 2021, then increased by 0.31% to $16.2 million in 2022, then skyrocketed by 52.92% to $24.8 million in 2023, then rose by 24.21% to $30.8 million in 2024, then surged by 63.46% to $50.4 million in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Shares Outstanding are $50.4 million (Q4 2025), $50.0 million (Q3 2025), and $49.8 million (Q2 2025).